Primodos APPG

I am a member of the All-Party Parliamentary Group (APPG) on Primodos, which brings together MPs and Peers from across Parliament to support families affected by hormone pregnancy tests and to continue scrutinising the evidence surrounding their use.

Primodos was a hormone pregnancy test prescribed to women in Britain during the 1960s and 1970s. For decades, families have raised concerns about an association between the drug and serious birth defects, and have campaigned for recognition, answers and justice.

The APPG works to ensure those concerns continue to be heard in Parliament. This includes examining emerging scientific evidence, engaging with researchers and medical experts, scrutinising the role and response of the Medicines and Healthcare products Regulatory Agency (MHRA), and pressing for appropriate parliamentary and Government attention.

In 2026, new research published in Birth Defects Research reviewed decades of evidence concerning hormone pregnancy tests. The authors concluded that HPTs are associated with human teratogenicity and identified a possible biological mechanism involving temporary oxygen deprivation and subsequent vascular disruption during embryonic development.

The APPG is examining the implications of this research and supporting efforts to secure further parliamentary scrutiny of the MHRA. I will continue working with colleagues across parties to ensure the evidence is properly considered and affected families’ voices remain at the heart of this work.